Trials / Unknown
UnknownNCT05043558
The Protective Effect of Prostaglandin on Coronary Microcirculation and Ventricular Remodeling After Reperfusion Therapy in Acute ST-segment Elevation Myocardial Infarction
- Status
- Unknown
- Phase
- Phase 1 / Phase 2
- Study type
- Interventional
- Enrollment
- 220 (estimated)
- Sponsor
- Shenzhen People's Hospital · Academic / Other
- Sex
- All
- Age
- 18 Years – 90 Years
- Healthy volunteers
- Not accepted
Summary
To explore the protective effect of prostaglandin sodium on coronary microcirculation function and ventricular remodeling after reperfusion treatment of acute ST-segment elevation myocardial infarction.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | beprostaglandin sodium | beprostaglandin sodium |
Timeline
- Start date
- 2022-01-01
- Primary completion
- 2022-01-10
- Completion
- 2022-01-12
- First posted
- 2021-09-14
- Last updated
- 2021-09-14
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT05043558. Inclusion in this directory is not an endorsement.